Follow Us On

Facebook  X  Linkedin  YouTube
 
 



Telehealth Services Extended Through December 2027




The House and Senate have both passed and the President signed the federal spending package, which includes HHS funding and an extension of telehealth services through December 2027.

 

This legislation is effective retroactively as of February 1, 2026. As a result, there is no lapse in telehealth coverage that would have otherwise occurred following the January 31, 2026, expiration under the continuing resolution. In addition, the continuing resolution has been extended for an additional two weeks and continues to include telehealth services. We have been advised that there will be no disruption in telehealth reimbursement, and that all claims will be paid retroactively.

 

Please see the enclosed document for the specific legislative language included in the bill.

 

Extension of the telehealth provisions has been one of the major focuses ASIPP's efforts. Over the past several months, we have worked closely with Chairman Guthrie, Chairman Comer, and Chairman Cassidy to advance this initiative. ASIPP is very pleased to have secured this outcome—while mid-term rather than permanent, the two-year extension provides important continuity and stability. The language remains unchanged, with the extension being the primary modification, as outlined in the enclosed text.

 

Thank you for your continued assistance and cooperation. We also extend our sincere appreciation to our congressional supporters who helped make this significant achievement possible.


Follow ASIPP to stay up-to-date with the news that matters to you!

Today is the deadline for

Abstract and Poster Presentations!

After reading the 2026 Abstracts & Poster Presentation Guidelines, complete the form by clicking on the submission form button below. 


Questions should be directed to Savannah Gold at 

sgold@asipp.org or 270.554.9412, ext 4219. 

A limited number of qualifying residents/fellows will receive a scholarship to attend the ASIPP 28th Annual Meeting, March 19-21, 2026 at the Hilton New Orleans Riverside. Recipients of this scholarship with receive reimbursement of their meeting registration, and up to three nights stay at the host hotel. This includes room block rate and tax.


Deadline to apply is February 15, 2026.


Click here for more information.

Join Us in New Orleans for ASIPP 2026

Earn CMEs, Expand Networks, and Explore the Future of Pain Management

For a limited-time when two full Annual Meeting registrations are completed, two registrations are provided at no additional cost! This special registration offer makes it easier to bring colleagues or members of your staff to the annual meeting.


Group attendance encourages shared learning, stronger collaboration, and a unified approach to implementing best practices in interventional pain management.

JOIN or RENEW your ASIPP Membership for the best registration rates.

 



RESERVE your HOTEL ROOM TODAY!


Discounted room rates end

February 24.

Hands-On Cadaver Workshops

 

Don't miss the Hands-On Cadaver Workshops taking place March 20 and 21 alongside the Annual Meeting in New Orleans!


These workshops offer practical, guided training in key interventional procedures. This is an invaluable opportunity to sharpen your skills and gain confidence through real-time, instructor-led practice.


  • PNS

Sponsored by Curonix 
(non-CME)


  • Regenerative Medicine

(8 CMEs)



  • Interventional Techniques

(8 CMEs)

 
 

40% OFF

new individual Annual Meeting registrations for a limited time!

 

Be sure to enter code SAVE40 at checkout to save!

Applies to new, individual registrations only.

Offer may not be combined with other discounts.

 

Study Finds Surprising Link Between Aspirin in Seniors and Cancer Mortality

Longer follow-up of the ASPREE cohort is warranted, says researcher

 

Key Takeaways


• Among more than 19,000 older adults, cancer incidence during 10 years of follow-up was almost identical in patients who used aspirin and those who did not.


• Use of aspirin was associated with increased cancer-related mortality.


• Aspirin was linked to a reduced risk of melanoma and an increased risk of brain cancer, though this was based on small numbers of events.

Low-dose aspirin was not associated with a reduced incidence of cancer in older adults, but was associated with an increased risk of dying of cancer, according to a cohort study of participants from the randomized ASPREE trial.


Among more than 19,000 adults with a mean age of 75, cancer incidence during 10 years of follow-up was almost identical in patients who used aspirin and those who did not (HR 0.98, 95% CI 0.92-1.05). The risk of dying of cancer was 15% higher in patients who took low-dose aspirin.


Click here to read the full article.

Upcoming ASIPP Webinars

Register today!

ASIPP is launching a new webinar series focused on Regenerative Medicine!


Join us on February 11 for the first webinar, complimentary: Integrating Regenerative Medicine into Your Pain Practice: Why, What, and How.




More Pain at Discharge Tied to Higher Chances of Readmission  




Patients with higher intensity of pain at hospital admission, during the stay, and at discharge were more likely to be readmitted, with pain at discharge as the strongest independent predictor for early readmission.

 

METHODOLOGY:

  • Researchers conducted a retrospective cohort study to examine whether the intensity of pain that patients felt at different timepoints in the hospital stay predicted if they would be readmitted later.
  • They included 7277 adults (mean age, 68.7 years; 55.5% female) admitted to internal medicine wards across a Swiss public hospital network between 2020 and 2023, with a hospital stay of at least 48 hours.
  • Nurses recorded pain reported by patients using an 11-point visual analog scale, in which 0 indicated no pain and 10 the worst pain imaginable. Pain was documented at admission, at every nursing shift during the stay, and at discharge.
  • Researchers assessed all-cause readmissions at 18 and 30 days and at 3, 6, and 9 months after discharge.


Click here to read the full article.

GUIDELINES

Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP)


Laxmaiah Manchikanti, MD, Riya Navani, Annu Navani, MD, Mahendra Sanapati, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye, PharmD, Amol Soin, MD, Devi Nampiaparampil, MD, Kenneth D. Candido, MD, Alaa Abd-Elsayed, MD, Theodore T. Sand, PhD, Navneet Boddu, MD, Sairam Atluri, MD, Anss Annie Augustine, BDS, Dajie Wang, MD, John Santa Ana, DO, Lady Christine Ong Sio, MD, Vidyasagar Pampati, MSc, Michael Khadavi, MD, Nebojsa Nick Knezevic, MD, PhD, Robert Farhat, DO, Shivam S. Shah, MD, Shounuck J. Patel, DO, Tom Nabity, Jr, MD, Alexander Bautista, MD, Aaron K. Calodney, MD, Joseph Cabaret, MD, Miles R. Day, MD, Paul J. Christo, MD, Sanjay Bakshi, MD, Shalini Shah, MD, Sheldon Jordan, MD, Sheri L. Albers, DO, Vivek Manocha, MD, and Joshua A. Hirsch, MD

The Opportunity:

  • Well-established group seeking an interventional pain physician with pain fellowship training
  • Comprehensive interventional pain management program with physicians, nurse practitioners, and two Ambulatory Surgery Centers
  • Established interventional pain management practice with strong clinical and research focus
  • High-volume practice that is ethical and fully legally compliant
  • Research and publication opportunities available
  • Early and generous partnership opportunities in both the practice and ASC


The Community:

  • Excellent quality of life in a county of more than 60,000 residents, with a regional drawing area exceeding 200,000
  • High standard of living with abundant recreational and social opportunities
  • Strong public school system and a private parochial elementary school
  • Convenient location: approximately 2.5 hours to Nashville and St. Louis; 3 hours to Memphis, Louisville, and Lexington
  • Daily one-hour flights to major international hubs, including Chicago O’Hare and Houston, TX


Please email Cindy Jackson at cindy@thepainmd.com with your current CV to schedule an interview or to learn more about this practice.

Our Sponsor

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


Click here to apply.

No additional cost for ASIPP members!

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.

The Hidden Dangers of 
Duplicate Medical Records

Study finds nearly five-fold higher odds of in-hospital 
death for patients with duplicate charts

 

Key Takeaways


• Patients with duplicate medical records were five times more likely to die in hospital and three times more likely to require intensive care than those without duplicate charts.


• Hospital length of stay was also 32% longer for those with duplicate records.


• Authors call for improvements on data integrity and research into potential interventions.

Patients with duplicate medical records had higher odds of adverse outcomes and longer hospital stays, a retrospective analysis from a large U.S. health system showed.


Compared to patients with single, accurate records, those with duplicate medical records had significantly higher odds of in-­hospital mortality (OR 4.7, 95% CI 3.7-6.0, P<0.0001), reported Hillary Western, MD, of the University of Colorado Anschutz Medical Campus in Aurora, and colleagues.


Click here to read the full article.

Our Sponsor


Colorado psychedelic therapy program considers expanding options



A review of rules governing Colorado's psychedelic therapy program will include potentially expanding the substances available for treatment.


Why it matters

The change would make Colorado the first state to use ibogaine — a psychoactive found in the roots of the African shrub iboga — for regulated medical treatment.


The big picture

The state will consider adding ibogaine to its Natural Medicine program after the Natural Medicine Advisory Board's recommendation last year, spokesperson Heather Draper told Axios Denver.


What they're saying

Ibogaine can be "super effective" at treating addiction, potentially even greater than psilocybin, The Center Origin CEO Elizabeth Cook explained.

  • The wellness center received the state's first healing center license to operate in downtown Denver last March. It hosted its first psychedelic therapy session last June, completing just over 95 sessions last year, Cook said.
  • The plant medicine has shown promising results for treating people with traumatic brain injuries.


Click here to read the full article.


NEW 2026 Dates Announced


February 7, March 14, April 18, May 23, & June 27, 2026


Apply now!




  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Fluoroscopy-Guided Transgluteal Radiofrequency Neurotomy of the Pudendal Nerve: A Retrospective Case Series


Danielle Levin, MD, Daniel Van Florcke, MD, Alopi Patel, MD, Lisa V. Doan, MD, and Meera Kirpekar, MD

Ultrasound-Guided Intraparaneurial, Extraradicular Hydrorelease for Adhesive Cervical Radiculopathy: A Case Report


Jenli Pan, MD, Trevor Johnson, MS, and Alaa Abd-Elsayed, MD

 
 

New Issue!

 

HEALTH POLICY RESEARCH

Updated Analysis of Declining Utilization Rate of 13% Epidural Procedures for Chronic Spinal Pain Management in the Traditional Medicare Population from 2019 to 2024


Laxmaiah Manchikanti, MD, Mahendra Sanapati, MD, Vidyasagar Pampati, MSc, Alan D. Kaye, MD, PhD, Nebojsa Nick Knezevic, MD, PhD, Annu Navani, MD, Devi Nampiaparampil, MD, and Joshua A. Hirsch, MD

NARRATIVE REVIEW

Selecting Neuromodulation Devices For Chronic Pain Conditions: A Narrative Review


Sayed Wahezi, MD, Alan D. Kaye, MD, PhD, Ugur Yener, MD, Corey Hunter, MD, Tony K. George, DO, Marom Bikson, PhD, Moorice Caparo, MD, Miles Day, MD, Yashar Eshraghi, MD, Andrew Kaufman, MD, Haijun Zhang, MD, Daniel Pak, MD, Scott Pritzlaff, MD, Hatice Begum Cifti, MD, Naum Shaparin, MD, Michael Schatman, PhD, Scott Lempka, PhD, and Laxmaiah Manchikanti, MD

RETROSPECTIVE REVIEW

Spinal Cord Stimulation Tolerance and Treatment by Waveform Conversion Using Externalized Trialing: A Retrospective Review


Sarafina Kankam, MD, Sayed Wahezi, MD, Ugur Yener, MD, Erika A. Petersen, MD, Hatice Begum Cifti, MD, and Alan D. Kaye, MD, PhD




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!